Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy

NCT06809751 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Central Serous Chorioretinopathy
Melatonin
Ocular Diseases
Visual Acuity
Macula Abnormality

Interventions

DRUG: melatonin 3mg
DRUG: Placebo Drug

Sponsor

Mohsen Pourazizi